The adjusted risk of major hemorrhage was more than twofold greater among patients with severe CKD Patients with chronic kidney disease (CKD) might require lower starting doses of the ...
Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently reviewing the oral therapy as an adjunct to insulin to help control glycemic ...